Cambrex reports fourth quarter full year 2010 results

Cambrex reports fourth quarter and full year 2010 results

12:11 PM, 7th June 2011
Cambrex reports fourth quarter and full year 2010 results

EAST RUTHERFORD, US: Cambrex Corporation announces its fourth quarter and full year results for the period ended December 31, 2010. The company has also appointed Shawn Cavanagh as Chief Operating Officer in January 2011. Moreover, Cambrex Zenara began supplying product for the launch of smoking cessation gum in India and received a Certificate of Good Manufacturing Practice (GMP) for its Hyderabad, India facility, following a successful audit, allowing shipment to all EU countries. Cambrex even signed an agreement with a Chinese partner to develop several new generic products in 2011, and Cavanagh will support the company to accelerate new product and strategic growth plans.


Highlights of full year: 

  • Reported sales increased by 8.2 per cent, and excluding the impact of foreign currency, sales increased 9.2 per cent compared to fourth quarter 2009.
  • Debt, net of cash was $86.3 million at the end of the fourth quarter 2010, an improvement of $4.2 million excluding $19.9 million of M&A related costs and a positive $0.9 million currency impact on foreign cash balances during the fourth quarter.
  • 2011 sales are expected to increase 3 to 7 per cent, excluding the impact of currency, and EBITDA is expected to be $43 to $49 million.


Fourth Quarter 2010 results

The fourth quarter 2010 sales of $ 63.5 million were 8.2 per cent higher than the fourth quarter 2009, indicating a sales increase of 9.2 per cent. Operating profit increased to $ 8.4 million in the fourth quarter 2010 from $ 3.7 million in the fourth quarter 2009. Income from continuing operations for the fourth quarter 2010 was $ 5.2 million or $ 0.18 per share compared to a loss of $ 2.8 million or $ 0.09 per share in the fourth quarter 2009.

Research and Development (R&D) expenses increased to $ 2.4 million in the fourth quarter 2010 from $ 2 million in the fourth quarter 2009 primarily due to the March 2010 acquisition of IEP, reduced utilization of certain R&D personnel on revenue-generating custom development projects and the development of new products and technology platforms.

(C) WOC News




Your Comments (Up to 2000 characters)
Please respect our community and the integrity of its participants. WOC reserves the right to moderate and approve your comment.

Related News

LyondellBasell technology selected for Braskem Idesa LDPE plant in Mexico

ROTTERDAM, NETHERLANDS: Braskem Idesa SAPI, a joint venture of Braskem SA and Grupo Idesa SA de CV, has selected LyondellBasell’s Lupotech T p ...

Read more
DENKA group gets new president, Shinsuke Yoshitaka

TOKYO, JAPAN: Denki Kagaku Kogyo Kabushiki Kaisha (DENKA) on 9 February, 2011 announced a change of directors and officers, which will be effective ...

Read more
Saudi SABIC optimistic on Q2 after big first quarter

CEO says “hopeful” Q2 results will be better than Q1 Sees Q2 demand to be similar to that of Q1 SABIC Q1 sales 45 bln riyals - CEO ...

Read more
Valspar acquires powder coatings manufacturer in Brazil

MINNEAPOLIS, US: To strengthen its presence in the fast-growing coatings markets in Latin America, Valspar Corporation has acquired Isocoat Tintas e ...

Read more
Westlake Chemical selects contractor for new Chlor-Alkali plant

HOUSTON, US: Westlake Chemical Corporation announced that Chlorine Engineers Corp Ltd has been selected as process technology provider and engineeri ...

Read more
Dow, Binhua to form PCE manufacturing facility in China

The joint venture will form a perchloroethylene (PCE) production facility in Binzhou, Shandong Province, China. The facility will look to supply mater ...

Read more uses cookies to ensure that we give you the best experience on our website. By using this site, you agree to our Privacy Policy and our Terms of Use. X